Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Does an early intensive interdisciplinary upper limb therapy programme following acute stroke improve outcome?
ISRCTN ISRCTN92548182
ClinicalTrials.gov identifier
Public title Does an early intensive interdisciplinary upper limb therapy programme following acute stroke improve outcome?
Scientific title
Acronym N/A
Serial number at source rctc135 R1805/6630
Study hypothesis To evaluate an early intensive interdisciplinary upper limb therapy programme for patients with acute stroke.
Objectives
1. To compare the upper limb impairment and function of stroke patients who receive an early intensive therapy programme targeting the upper limb (the intervention group) with those receiving conventional care (the control group) at 3 and 6 months post stroke.
2. To compare disability and quality of life of the intervention and control group at 3 and 6 months post stroke.
3. To compare the prevalence of post stroke upper limb pain between the intervention and control group at 3 and 6 months post stroke.
4. To develop a joint physiotherapy and occupational therapy record for the intervention group.
5. To describe and quantify the therapy received by the intervention and control group in the 6 months post stroke.
6. To elicit the vies of patients and carers about the therapy they have received.
7. To determine the net financial costs and benefits of an early intensive upper limb therapy programme following acute stroke.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cerebrovascular disease
Participants - inclusion criteria All patients admitted to North Tyneside General Hospital within 10 days of acute stroke who are resident within the borough will be assessed against the following eligibility criteria:
1. Pre-stroke Oxford Handicap Scale 1-3
2. Motor impairment of the upper limb
3. Medically stable
4. No previous major upper limb problem likely to influence assessments
5. Patient able to give informed consent
Participants - exclusion criteria A register of reasons for exclusion will be kept
Anticipated start date 03/01/1999
Anticipated end date 03/01/2002
Status of trial Completed
Patient information material
Target number of participants 123 (added 21/01/10; see publication)
Interventions 1. Early intensive therapy programme targeting the upper limb (intervention group)
2. Conventional care (control group)
Primary outcome measure(s) Action Research Arm Test at 6 months post stroke
Secondary outcome measure(s) 1. Motricity score (3 months and 6 months post stroke)
2. Upper limb function assessed by:
2.1. Action Research Arm Test (3 months)
2.2. Frenchay arm test (3 months and 6 months)
3. Disability assessed by Nottingham Extended Activities of Daily Living (E-ADL) (3 months and 6 months)
4. Nottingham Health Profile (6 months)
5. Upper limb pain (3 months and 6 months)
6. Patient and carer satisfaction (modified Hospsat & Homsat 6 months)
Sources of funding NHS Executive Northern and Yorkshire (UK)
Trial website
Publications 2003 results in http://www.ncbi.nlm.nih.gov/pubmed/12971702
Contact name Dr  Helen  Rodgers
  Address University of Newcastle
Centre for Health Services Research
21 Claremont Place
  City/town Newcastle upon Tyne
  Zip/Postcode NE2 4AA
  Country United Kingdom
  Tel +44 (0)191 222 8025
  Fax +44 (0)191 222 6043
  Email helen.rodgers@newcastle.ac.uk
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 23/01/2004
Last edited 21/01/2010
Date ISRCTN assigned 23/01/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central